Innovations in Hypertension Management: Renal Denervation (RDN)


Presented by the Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center.

ACKNOWLEDGEMENT
This activity is supported by an educational grant from Medtronic.

TUITION
Complimentary

ACCREDITATION STATEMENT
The activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center and PlatformQ LLC. The Albert Einstein College of Medicine of Yeshiva University is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
Live Internet Activity
The Albert Einstein College of Medicine of Yeshiva University designates this live internet activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Enduring Material
The Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

EBAC LogoInnovations in Hypertension Management: Renal Denervation (RDN) is accredited by the European Board for Accreditation in Cardiology (EBAC) for up to 3 hours of External CME credits.

Each participant should claim only those hours of credit that have actually been spent in the educational activity.

EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 3.0 hours of Category 1 credit for completing these programs.

DATE OF RELEASE/EXPIRATION
Live Activity
Wednesday, April 9, 2014 from 11:00 PM CET - 2:00 PM CET
Enduring Material
The enduring material will be available from April 9, 2014 to October 9, 2014

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

Define the epidemiology and pathophysiology of resistant hypertension
Identify causes of "pseudo-resistance," and outline strategies for achieving timely and appropriate diagnosis of resistant hypertension
Differentiate between secondary hypertension and resistant hypertension
Discuss the role of ambulatory or home blood pressure monitoring in the work-up of patients being evaluated for resistant hypertension
Identify the mechanisms by which renal nerves affect central sympathetic drive and blood pressure control
Differentiate between afferent and efferent renal nerves and discuss their role in modulating central sympathetic drive
Review current and investigational interventions that target renal nerves in order to modulate blood pressure
Outline the scientific evidence for renal nerve ablation as a management strategy for resistant hypertension
Describe the procedure for percutaneous renal artery sympathetic denervation
Provide an overview of the safety, efficacy and risk-benefit profile of renal denervation as a treatment for resistant hypertension

INTENDED AUDIENCE
This activity is intended for European internists, primary care physicians, hypertension specialists, cardiologists and health care professionals involved with the diagnosis and treatment of patients with resistant hypertension.

ESTIMATED TIME TO COMPLETE
This activity consists of three sessions, which should each take approximately 1 hour to complete, for a total of 3 hours.

METHOD OF PARTICIPATION
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that each module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

In compliance with EBAC/ EACCME guidelines, all speakers/ chairpersons participating in this programme have disclosed potential conflicts of interest that might cause a bias in the presentations. The Organising Committee is responsible for ensuring that all potential conflicts of interest relevant to the programme are declared to the audience prior to the CME activities.

Presenters: Disclosures:
Professor Markus Schlaich Grants/Research: Medtronic
Consultant: Medtronic, Abbott:
Other: Medtronic, Boston Scientific, Abbott, Boehringer Ingelheim, MSD (Merck Worldwide)
Professor Luis Ruilope Consultant: Medtronic, St. Jude
Professor Deepak Bhatt Grants/Research: Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Roche, Sanofi Aventis, The Medicines Company
Jessica Zwerling, MD Grants/Research: Medtronic Institutional (to Columbia University), Boston Scientific Institutional (to Columbia University), Vascular Dynamics Institutional (to Columbia University), St. Jude Medical Institutional (to Columbia University), Abiomed Institutional (to Columbia University), Abbott Vascular Institutional (to Columbia University)
Einstein-Montefiore Center for Continuing Medical Education The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine of Yeshiva University have no disclosures to report.
Mark Menegus, MD Has nothing to disclose.
PlatformQ Health, Inc  
Randi O'Hara, Senior Program Manager Has nothing to disclose.
Alyce Kuklinski, NP, RN, Senior Medical Director Has nothing to disclose.

CONTACT INFORMATION
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

For issues with your CME Certificate, contact CardioCareLive at 00.1.617.938.6062 or at Support@CardioCareLive.com

 

New Directions in the Management of Acute Heart Failure

Presented by Penn State College of Medicine.

SUPPORT
This activity is supported by an educational grant from the Novartis Pharmaceuticals Corporation

ACCREDITATION

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Penn State College of Medicine and PlatformQ. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Penn State College of Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF ORIGINAL RELEASE/EXPIRATION
Released May 28, 2014. Expires November 28, 2014

ESTIMATED TIME TO COMPLETE ACTIVITY
60 minutes per session for a possible total of 1 hour.

ACTIVITY DESCRIPTION

Heart failure, which already affects 5 million Americans, will affect 8 million by 2030, and direct and indirect costs to treat this condition could more than double from the current $31 billion to $70 billion by 2030. The mortality associated with this condition, both chronic heart failure and acute heart failure, is high. It is estimated that half of all Medicare patients hospitalized for heart failure die within 3 years. These figures encompass both chronic and acute heart failure. Acute heart failure, however, is common in the elderly, who may have a variety of heart-related conditions and other comorbidities. It is a major public health problem and the leading cause of hospitalization among patients older than 65 years of age. In the US, there are approximately 1 million hospitalizations for acute heart failure each year. Although improvements have occurred in hospital mortality and length of stay for acute heart failure, long-term outcomes remain unacceptably poor.

EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be better able to:

Outline the benefits and limitations of the current standard of care for treatment of patients with acute heart failure
Evaluate the results of recent clinical trials examining novel therapies for the treatment of acute heart failure


TARGET AUDIENCE

Cardiologists, hospitalists, internists, emergency room physicians, primary care physicians, and other health care providers caring for patients with acute heart failure. The secondary audience may include nurse practitioners, physician assistants, cardiology nurses and pharmacists.

FORMAT
Internet

METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this activity. During the period of May 28, 2014 through November 28, 2014, participants must:

1. Read the educational objectives and faculty disclosures
2. Listen to the materials and study the educational activity
3. Complete and submit the online post-test and the evaluation form


HARDWARE & SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE INFORMATION

FACULTY NAME AND LECTURE TITLE(S): RELATIONSHIP(S):
Clyde Yancy, MD, MSc, FACC, FAHA, MACP
Has nothing to disclose
G. Michael Felker, MD, MHS FACC, FAHA
Consultant/Advisor: Novartis, Amgen, Roche Diagnostics
Research Grant: Novartis, Amgen, Roche Diagnostics, Otsuka Pharmaceutical, Trevena

PlatformQ and Penn State College of Medicine staff and faculty and involved in the development and review of this activity have disclosed no relevant financial relationships.

ACTIVITY DIRECTOR
Clyde Yancy, MD, MSc, FACC, FAHA, MACP
Chief, Division of Medicine-Cardiology
Northwestern University Feinberg School of Medicine

CONTACT INFORMATION
Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course #G5573-14-V for the live activity and G5574-14-T for the enduring activity.

DISCLAIMERS (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Penn State College of Medicine, CardioCareLive, PlatformQ Health or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

 

Dyslipidemia Management 2014: Views on the News

Presented by the Northwestern University Feinberg School of Medicine.

ACKNOWLEDGEMENT
This activity is supported by educational grants from Merck and Lilly
For further information concerning Lilly grant funding visit www.lillygrantoffice.com

TUITION
Complimentary

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Northwestern University Feinberg School of Medicine and PlatformQ Health Education. LLC. The Northwestern University Feinberg School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
Live Activity
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Enduring Material
The Northwestern University Feinberg School of Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2 hours of Category 1 credit for completing these programs.

DATE OF RELEASE/EXPIRATION
Live Activity
Thursday, June 5, 2014 from 11:00AM to 1:00PM ET
Enduring Material
June 5, 2014 to December 5, 2014

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

Assess the safety, efficacy and tolerability profiles of emerging therapies for dyslipidemia and their potential role in improving patient health outcomes
Summarize key tenets of CV risk assessment and management as outlined in the newly released ACC/AHA cholesterol guidelines.

TARGET AUDIENCE
This activity is intended for cardiologists, internists, family physicians, and other health care providers caring for patients with dyslipidemia.

ESTIMATED TIME TO COMPLETE
The activity consists of two sessions, which should take approximately 2.0 hours to complete.

METHOD OF PARTICIPATION
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimate that each module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE
In accordance with ACCME Standards for Commercial Support of Continuing Medical Education and the Feinberg School of Medicine's (FSM) disclosure policy for CME activities, all individuals who contribute to the content or the identification / resolution of potential conflicts of interest must disclose any relationship they may have with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients within the preceding 12 months of the activity. Such disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influence by the faculty's relationships(s) or financial interest with said companies.

Presenters: Disclosures:
Clyde Yancy, MD, MSc Has nothing to disclose.
Jennifer G. Robinson, MD, MPH Consultant: Amgen, Hoffman LaRoche, Merck, Pfizer, Sanofi
Research Grants: Amarin, Amgen, AstraZeneca, Daiichi-Sankyo, Genentech/Hoffman La Roche, Glaxo-Smith Kline, Merck, Regeneron/Sanofi, Zinfandel/Takeda
Donald Lloyd-Jones, MD ScM Has nothing to disclose.
Michael H. Davidson, MD Consultant: AbbVie, Aegerion, Alexion, Amgen, Esperion, Lipimetix, Pfizer, Sanofi, Vindico
Speaker's Bureau: Merck
Employment: Omthera Pharmaceuticals, Inc. subsidiary of AstraZeneca
FSM's CME Leadership  
John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education Has nothing to disclose.
Genevieve Napier, CME Director Has nothing to disclose.
Jennifer Banys, Tristan Brown and Michelle Mallery, CME Project Specialists Have nothing to disclose.
PlatformQ Health, Inc  
Deborah Sharkey, Associate Program Manager Has nothing to disclose.
Alyce Kuklinski, NP, RN, Senior Medical Director Has nothing to disclose.

CONTACT INFORMATION
Please send all inquiries to: Northwestern University Feinberg School of Medicine, Office of Continuing Medical Education, by phone: 312-503-8533 or email: nums-cme@northwestern.edu.

For issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com

 
CardioCareLive
Watch Connect online with thousands of your peers.
Connect Engage in real-time Q&A with top factuly.
Choose Learn about the latest treatment options.
Connect Earn AMA PRA
Category 1 Credits
™.